secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001104659-24-008937
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences raises ~$3.44M in registered direct offering at $0.609/share
--------------------------------------------------------------------------------

- Gross proceeds expected $3.44M from 5,644,061 shares (or prefunded warrants) at $0.609 each.
- Concurrent private placement: warrants for 11,288,122 shares at $0.609, exercisable upon stockholder approval, 5-year term.
- Exercise price of 3,113,213 existing outstanding warrants reduced to $0.609 and expiration extended to 2028, subject to shareholder approval.
- Net proceeds for therapeutic DNA production development and general corporate purposes; closing expected Feb 2, 2024.
- Placement agent Maxim Group LLC; lock-up on insiders for 60 days post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924008937/0001104659-24-008937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924008937/tm244700d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-008937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer